| Outcome Measures: |
Primary: Percentage of insulin-treated patients experiencing at least one hypoglycaemia (severe/non-severe), During the one-month follow-up after inclusion in study | Secondary: Percentage of insulin-treated patients experiencing at least one severe hypoglycaemia, During the last 12 months before inclusion in study|Percentage of insulin-treated patients experiencing at least one severe hypoglycaemia, During the one-month follow-up after inclusion in study|Percentage of insulin-treated patients experiencing at least one non-severe symptomatic hypoglycaemia, During the one-month follow-up after inclusion in study|Percentage of insulin-treated patients experiencing at least one asymptomatic hypoglycaemia, During the one-month follow-up after inclusion in study|Percentage of insulin-treated patients experiencing at least one hypoglycaemia (overall/severe/non-severe), During the one-month follow-up after inclusion in study|Rate of episodes (event/patient/month) in insulin-treated patients of severe hypoglycaemia, During the last 12 months before inclusion in study|Rate of episodes (event/patient/month) in insulin-treated patients of severe hypoglycaemia, During the one-month follow-up after inclusion in study|Rate of episodes (event/patient/month) in insulin-treated patients of non-severe symptomatic hypoglycaemia episodes, During the one-month follow-up after inclusion in study|Rate of episodes (event/patient/month) in insulin-treated patients of asymptomatic hypoglycaemia episodes, During the one-month follow-up after inclusion in study|Overall/severe/non-severe hypoglycaemia episodes (event/patient/month), During the one-month follow-up after inclusion in study|Extra diagnostic tests carried out (number of extra self-monitoring plasma glucose (SMPG) test following the episode), During the one-month follow-up after inclusion in study|Additional consultations to a specialist and/or general practitioner (GP), visit to emergency department, hospitalizations, transportation and assistance of a care-giver, During the one-month follow-up after inclusion in study|Change in planned daily activities; sleep, food consumption, physical activities (sport), driving, social life, During the one-month follow-up after inclusion in study|Change in planned daily activities; work: effectiveness, missing hours or days for sick leave, During the one-month follow-up after inclusion in study
|
